Announcements Trials
Browse Landscape

Phase

Phase 4 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Breast Neoplasms 20Pain, Postoperative 5Stomach Neoplasms 4Pancreatic Neoplasms 4Neoplasms 4Lung Neoplasms 4Carcinoma, Non-Small-Cell Lung 4Brain Neoplasms 4Prostatic Neoplasms 3Myoma 3Leiomyoma 3Head and Neck Neoplasms 3Glioblastoma 3Colorectal Neoplasms 3Agnosia 3Stomatitis 2Skin Neoplasms 2Postoperative Hemorrhage 2Ovarian Neoplasms 2Neoplasm Metastasis 2Melanoma 2Lymphoma, Non-Hodgkin 2Hemorrhage 2Fatigue 2Colonic Neoplasms 2Chronic Pain 2Carcinoma, Hepatocellular 2Water-Electrolyte Imbalance 1Vulvodynia 1Uterine Cervical Neoplasms 1

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4pimonidazole 2TH 302 2gadobutrol 1fluoromisonidazole 1Surgical Procedures, Operative 1Sodium Chloride 1Sevoflurane 1Saline Solution 1Radiotherapy 1Propofol 1Positron Emission Tomography Computed Tomography 1Pancreaticoduodenectomy 1Oxygen 1NVP-BKM120 1Ketamine 1Gemcitabine 1Ferrosoferric Oxide 1Dexmedetomidine 1Blood Specimen Collection 1Biopsy 1Bacterial Load 1Atovaquone 13-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Completed × Hypoxia × Sodium Chloride × Clear all
NCT04266665 2026-03-25

Effect of Dexmedetomidine on Brain Homeostasis and Neurocognitive Outcome

Aristotle University Of Thessaloniki

Phase 4 Completed
56 enrolled
CNS

Neuroinflammatory Diseases, Hypoxia, Brain Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡